TUDINO VALERIA | Elenco docenti

placeholder-icon272x331.png

Valeria

Tudino

Ricercatore Legge 240/10 - tempo determinato

Marotta, L., Giammarino, F.M.P.R., Senenou Tambou, B.B., Tudino, V., Butini, S., Broccardo, L., et al. (2026). Oxyprenyl–chalcones as antibacterial hits: design of experiments-optimized synthesis, antibacterial evaluation, early drug-like profiling and biodegradability prediction. RSC MEDICINAL CHEMISTRY, 17(3), 1573-1585 [10.1039/d5md00839e]. - dettaglio
Tudino, V., Rossi, S., Milioni, L., Cosenza, C., Carullo, G., Gemma, S., et al. (2026). Unveiling the Role of
Pseudomonas aeruginosa
Quorum Sensing Inhibitors: The Road So Far. THE CHEMICAL RECORD [10.1002/tcr.202500359]. - dettaglio
Tudino, V., Mellini, M., Milioni, L., Carullo, G., Rossi, S., Giammarino, F.M.P.R., et al. (2026). Quinazolinone-Based PqsR Modulators Suppress Quorum-Sensing–Driven Virulence in
Pseudomonas aeruginosa. ACS INFECTIOUS DISEASES, 12(3), 1176-1191 [10.1021/acsinfecdis.5c01128]. - dettaglio
Carullo, G., Falbo, F., Tudino, V., Song, J., Fava, M., Fontana, A., et al. (2026). Targeting class I histone deacetylases triggers antitumor responses in colorectal cancer in vitro and in vivo. JOURNAL OF MEDICINAL CHEMISTRY, 69(2), 1049-1074 [10.1021/acs.jmedchem.5c02237]. - dettaglio
Cursaro, I., Frattaruolo, L., Scalvini, L., Contri, C., Bichicchi, A., Tardiolo, N., et al. (2025). New Vanillyl-capped HDAC inhibitors exhibit anti-tumor efficacy in neuroblastoma and glioblastoma cells. BIOORGANIC CHEMISTRY, 166 [10.1016/j.bioorg.2025.109085]. - dettaglio